Australia markets closed

Xenon Pharmaceuticals Inc. (XENE)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
39.88-0.43 (-1.07%)
At close: 04:00PM EDT
39.09 -0.79 (-1.98%)
After hours: 04:28PM EDT
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-182,393
-182,393
-125,373
-78,882
-28,837
Depreciation & amortisation
3,541
3,541
1,624
906
644
Deferred income taxes
-292
-292
-44
58
-285
Stock-based compensation
32,372
32,372
20,376
10,017
5,677
Change in working capital
5,635
5,635
-676
-2,647
-26,089
Accounts receivable
130
130
1,757
-459
-1,032
Other working capital
-150,944
-150,944
-101,324
-71,552
-50,761
Other non-cash items
-
-
-
-
216
Net cash provided by operating activities
-145,327
-145,327
-98,430
-69,502
-48,124
Cash flows from investing activities
Investments in property, plant and equipment
-5,617
-5,617
-2,894
-2,050
-2,637
Purchases of investments
-793,907
-793,907
-551,137
-389,474
-228,897
Sales/maturities of investments
682,354
682,354
258,028
144,754
214,710
Net cash used for investing activities
-117,170
-117,170
-296,003
-246,770
-16,824
Cash flows from financing activities
Debt repayment
-
-
0
0
-16,743
Common stock issued
353,487
353,487
277,766
447,283
102,456
Net cash used provided by (used for) financing activities
353,522
353,522
278,471
447,543
85,795
Net change in cash
91,401
91,401
-118,446
130,679
20,254
Cash at beginning of period
57,242
57,242
175,688
45,009
24,755
Cash at end of period
148,643
148,643
57,242
175,688
45,009
Free cash flow
Operating cash flow
-145,327
-145,327
-98,430
-69,502
-48,124
Capital expenditure
-5,617
-5,617
-2,894
-2,050
-2,637
Free cash flow
-150,944
-150,944
-101,324
-71,552
-50,761